NO964482D0 - Fremgangsmåte ved fremstilling av doxorubicin - Google Patents

Fremgangsmåte ved fremstilling av doxorubicin

Info

Publication number
NO964482D0
NO964482D0 NO964482A NO964482A NO964482D0 NO 964482 D0 NO964482 D0 NO 964482D0 NO 964482 A NO964482 A NO 964482A NO 964482 A NO964482 A NO 964482A NO 964482 D0 NO964482 D0 NO 964482D0
Authority
NO
Norway
Prior art keywords
doxorubicin
preparation
Prior art date
Application number
NO964482A
Other languages
English (en)
Other versions
NO964482L (no
Inventor
Inventi Augusto Solari
Umberto Breme
Anna Luisa Colombo
Charles Richard Hutchinson
Sharee Otten
Claudio Scotti
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO964482D0 publication Critical patent/NO964482D0/no
Publication of NO964482L publication Critical patent/NO964482L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
NO964482A 1995-02-27 1996-10-22 Fremgangsmåte ved fremstilling av doxorubicin NO964482L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/396,218 US5695966A (en) 1995-02-27 1995-02-27 DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin
PCT/EP1996/000692 WO1996027014A1 (en) 1995-02-27 1996-02-20 Process for preparing doxorubicin

Publications (2)

Publication Number Publication Date
NO964482D0 true NO964482D0 (no) 1996-10-22
NO964482L NO964482L (no) 1996-12-23

Family

ID=23566340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964482A NO964482L (no) 1995-02-27 1996-10-22 Fremgangsmåte ved fremstilling av doxorubicin

Country Status (19)

Country Link
US (2) US5695966A (no)
EP (1) EP0763112B1 (no)
JP (1) JPH10505506A (no)
KR (1) KR100414999B1 (no)
CN (1) CN1118574C (no)
AR (1) AR001014A1 (no)
AT (1) ATE178653T1 (no)
AU (1) AU711706B2 (no)
CA (1) CA2188571A1 (no)
DE (1) DE69601993T2 (no)
ES (1) ES2132891T3 (no)
FI (1) FI112251B (no)
HU (1) HU220530B1 (no)
IL (1) IL117246A0 (no)
NO (1) NO964482L (no)
RU (1) RU2205222C2 (no)
TW (1) TW419521B (no)
WO (1) WO1996027014A1 (no)
ZA (1) ZA961555B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695966A (en) * 1995-02-27 1997-12-09 Pharmacia & Upjohn S.P.A. DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin
US5976830A (en) * 1996-05-24 1999-11-02 The Ohio State University Research Foundation Methods of producing doxorubicin
GB2330144B (en) * 1997-03-06 2001-05-02 Pharmacia & Upjohn Spa Process for preparing doxorubicin
WO1999055829A2 (en) * 1998-04-24 1999-11-04 Pharmacia & Upjohn S.P.A. Process for preparing doxorubicin
JP4850698B2 (ja) * 2003-04-25 2012-01-11 ノース・キャロライナ・ステイト・ユニヴァーシティ 細胞表面タンパク質相同体をコードするアシドフィルス菌核酸配列及びその使用
WO2006111561A1 (en) * 2005-04-21 2006-10-26 Dsm Ip Assets B.V. Improved microbial production of anthracyclins
KR100629896B1 (ko) * 2005-04-28 2006-09-29 인하대학교 산학협력단 방선균 독소루비신 고생산 균주 및 독소루비신 생합성유전자군의 발현양상 분석을 위한 마이크로어레이칩
CN101016533B (zh) * 2005-11-09 2010-05-19 上海医药工业研究院 一种蒽环类抗生素产生工程菌及其应用
CN103087124B (zh) * 2012-11-21 2016-01-13 浙江海正药业股份有限公司 一种制备阿霉素的方法
CN104059892A (zh) * 2013-03-18 2014-09-24 江苏禾昌生物科技有限公司 柔红霉素c-14羟化酶突变体及其基因工程菌的生产方法
CN105861455B (zh) 2016-05-16 2018-10-26 浙江海正药业股份有限公司 DoxA蛋白突变体及其编码基因与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159496A (en) * 1981-03-28 1982-10-01 Sanraku Inc Preparation of adriamycin
US5695966A (en) * 1995-02-27 1997-12-09 Pharmacia & Upjohn S.P.A. DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin
US5976830A (en) * 1996-05-24 1999-11-02 The Ohio State University Research Foundation Methods of producing doxorubicin

Also Published As

Publication number Publication date
FI112251B (fi) 2003-11-14
WO1996027014A1 (en) 1996-09-06
EP0763112B1 (en) 1999-04-07
RU2205222C2 (ru) 2003-05-27
KR100414999B1 (ko) 2004-04-28
CA2188571A1 (en) 1996-09-06
AU4878496A (en) 1996-09-18
ES2132891T3 (es) 1999-08-16
HUP9603259A3 (en) 2000-04-28
KR970702922A (ko) 1997-06-10
US5695966A (en) 1997-12-09
ZA961555B (en) 1996-08-19
US5786190A (en) 1998-07-28
DE69601993T2 (de) 1999-11-04
FI964229A (fi) 1996-10-21
AR001014A1 (es) 1997-08-27
ATE178653T1 (de) 1999-04-15
AU711706B2 (en) 1999-10-21
FI964229A0 (fi) 1996-10-21
HU220530B1 (hu) 2002-03-28
JPH10505506A (ja) 1998-06-02
DE69601993D1 (de) 1999-05-12
CN1118574C (zh) 2003-08-20
IL117246A0 (en) 1996-06-18
CN1147835A (zh) 1997-04-16
HUP9603259A2 (en) 1997-05-28
EP0763112A1 (en) 1997-03-19
TW419521B (en) 2001-01-21
MX9605018A (es) 1998-05-31
NO964482L (no) 1996-12-23

Similar Documents

Publication Publication Date Title
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
NO985064D0 (no) FremgangsmÕte ved fremstilling av sildenafil
IL117188A0 (en) Process for the preparation of thietanones
HUP9602957A3 (en) Process for the preparation of dihalo-azolopyrimidines
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO974316D0 (no) Fremgangsmåte ved fremstilling av avfasede katetre
NO975176D0 (no) Fremgangsmåte ved fremstilling av lercanidipin-hydroklorid
NO965113L (no) Fremgangsmåte ved fremstilling av et steroid-ketalderivat
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO964482L (no) Fremgangsmåte ved fremstilling av doxorubicin
NO972240D0 (no) Fremgangsmåte ved fremstilling av N-fosfonometylglycin
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO960307D0 (no) Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU5486396A (en) Process for the preparation of spiroindolines
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
NO963432D0 (no) Fremgangsmåte for fremstilling av dimetyldiklorsilan
IL118973A (en) Process for the preparation of substituted aminocarbonyltriazolinones
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
NO304883B1 (no) FremgangsmÕte ved fremstilling av hydrazin-nitroform
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
AU5698696A (en) Process for the preparation of substituted 5-hydroxy-oxazoli din-4-one